A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity
about
The SLC6 transporters: perspectives on structure, functions, regulation, and models for transporter dysfunctionSyntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transportersInsulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasisMonoamine TransportSubcellular localization of the antidepressant-sensitive norepinephrine transporter.Norepinephrine transporter variant A457P knock-in mice display key features of human postural orthostatic tachycardia syndrome.Dopamine transporter trafficking: rapid response on demand.Amphetamine induces dopamine efflux through a dopamine transporter channel.Structure and regulatory interactions of the cytoplasmic terminal domains of serotonin transporter.Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression.Involvement of threonine 258 and serine 259 motif in amphetamine-induced norepinephrine transporter endocytosis.Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.Regulation of monoamine transporters: Role of transporter phosphorylation.Syntaxin 1A regulates surface expression of beta-cell ATP-sensitive potassium channels.SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.Molecular basis for the interaction of the mammalian amino acid transporters B0AT1 and B0AT3 with their ancillary protein collectrinCalcium-dependent interactions of the human norepinephrine transporter with syntaxin 1A.PKC-Dependent GlyT1 Ubiquitination Occurs Independent of Phosphorylation: Inespecificity in Lysine Selection for Ubiquitination.Functional mechanisms of neurotransmitter transporters regulated by lipid-protein interactions of their terminal loops.Monoamine transporters: vulnerable and vital doorkeepers.Phosphatidylinositol 4,5-biphosphate (PIP(2)) lipids regulate the phosphorylation of syntaxin N-terminus by modulating both its position and local structure.Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.The solute carrier 6 family of transportersDifferential Internalization Rates and Postendocytic Sorting of the Norepinephrine and Dopamine Transporters Are Controlled by Structural Elements in the N Termini.Radiotracers for cardiac sympathetic innervation: transport kinetics and binding affinities for the human norepinephrine transporter.Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmissionThe dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines.Growth factor signals in neural cells: coherent patterns of interaction control multiple levels of molecular and phenotypic responsesGoing with the flow: trafficking-dependent and -independent regulation of serotonin transport.Regulated norepinephrine transporter interaction with the neurokinin-1 receptor establishes transporter subcellular localization.A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transportersRab 11 regulates constitutive dopamine transporter trafficking and function in N2A neuroblastoma cells.Differentiation of rodent behavioral phenotypes and methylphenidate action in sustained and flexible attention tasksDopamine transporters depolarize neurons by a channel mechanism.Synuclein modulation of monoamine transporters.Vesicular and plasma membrane transporters for neurotransmitters.Dynamic monitoring of NET activity in mature murine sympathetic terminals using a fluorescent substrateRab11 supports amphetamine-stimulated norepinephrine transporter trafficking.Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior
P2860
Q26825461-757F16CC-4537-44B3-ABEA-73094CDD209AQ27863388-22CC7CC6-5E07-40F5-B7C3-8F475AC9E332Q28476265-1D90D818-0843-4281-B6A4-295FB17B9A22Q28483930-19DF8DA8-979A-470B-B078-86E492B3FD93Q30230904-9287FDD2-5E45-4336-B3F2-12527F4D5E7CQ30439090-C5E2B2EF-0B70-4C8C-A83F-12CC0D9EEFE9Q33162642-6B1E4ECB-E57F-48B7-8064-DCCE7A5CD3CFQ33654916-CA8E1E0C-0606-4772-B32E-16BC80F8D47BQ33858611-5EB47164-AF5A-447B-8FAB-99E01B734C74Q34103328-45AECA0F-AC8B-43CB-92F7-9E2E096BDCE4Q34103973-ACC0B3A7-7F93-41AB-A1A4-9D78D1BDC5FFQ34130247-73925D36-0A3D-42F8-A65B-D17457A64027Q34161514-5E52F7B1-80DB-4365-9EFF-35808C29C0B2Q34540543-7BBAC892-ADF4-4A4D-B4EE-BC49AEF33DCCQ34718049-A393B582-807E-4846-B40D-82269099B647Q35150201-9612AA0B-66F5-46A5-B0CD-4C5D39133452Q35736694-B07E8480-06AC-42D5-926D-C57CE8A409B6Q35741009-D0C46C90-65A9-4BAA-B1A2-1683D31C5030Q35791755-82F0A089-A718-4D6C-8097-3B08896BB03BQ35850518-73E26EAD-A949-4560-8415-4B9041D42BA6Q35877150-1D4BF9C7-6266-4967-99B4-2D363765358BQ36292164-3258021B-D1FE-4246-B663-B6A1660CFB5BQ36341704-2E05D39C-99CA-4175-9C93-15F9826CF26AQ36346899-CB913F58-FF40-42F9-B507-54F1EA3A0DB6Q36674628-F806D9C6-E653-4470-A812-7A205A086056Q36681117-C689A2FD-80D9-40FE-9735-4A65124A6B75Q36861106-121AB87E-7264-482A-A4C3-C6583BD9F53AQ37004117-7FE0B953-68AA-4C91-8B57-FADE5FAA46A0Q37068068-EFACFDFC-0190-49A2-A7A9-2981BCFC2806Q37150439-83CE13A7-55CF-4407-9340-BBEBA0D5C35FQ37213783-BADED2E7-C794-4301-9A41-B47FF775BEB2Q37312177-62438849-B534-4517-85E5-456C60308519Q37369278-B3E2E65F-BA22-43E9-A355-C70F861D27FBQ37451921-F47827C0-12F2-4FFA-A219-8E6E77004224Q37619225-92649027-D22A-455D-A177-F816FC323221Q37852164-B73346A6-A0B9-4CE4-A04C-84864374782CQ37971367-8C2E44BE-203A-4C64-8716-DF43FF236C8CQ39300253-3B6E9F9E-E021-41E8-AD74-8B551E60CBD5Q42226842-7138B5E9-24D8-49F5-83BE-9088A2B72A82Q42446087-C9FD6016-D406-4290-A14B-E90A91161FD7
P2860
A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity
description
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im März 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/03/01)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/03/01)
@nl
наукова стаття, опублікована в березні 2003
@uk
مقالة علمية (نشرت في مارس 2003)
@ar
name
A regulated interaction of syn ...... techolamine clearance capacity
@ast
A regulated interaction of syn ...... techolamine clearance capacity
@en
A regulated interaction of syn ...... techolamine clearance capacity
@nl
type
label
A regulated interaction of syn ...... techolamine clearance capacity
@ast
A regulated interaction of syn ...... techolamine clearance capacity
@en
A regulated interaction of syn ...... techolamine clearance capacity
@nl
prefLabel
A regulated interaction of syn ...... techolamine clearance capacity
@ast
A regulated interaction of syn ...... techolamine clearance capacity
@en
A regulated interaction of syn ...... techolamine clearance capacity
@nl
P2093
P1476
A regulated interaction of syn ...... techolamine clearance capacity
@en
P2093
Aurelio Galli
Kristopher M Kahlig
Michael W Quick
Randy D Blakely
Sally Schroeter
Subramaniam Apparsundaram
Valentina Savchenko
P304
P356
10.1523/JNEUROSCI.23-05-01697.2003
P407
P577
2003-03-01T00:00:00Z